Figure 1.
Receiver operating characteristic (ROC) curves in LMR-1 (A) and LMR-week 6 (B). LMR-1, lymphocyte-to-monocyte ratio baseline; LMR-week 6, lymphocyte-to-monocyte ratio 6 weeks after the start of PD-1 inhibitors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.